PML and EIF4E

  • Number of citations of the paper that reports this interaction (PMID 11500381)
  • 47

PML

EIF4E

Gene Name promyelocytic leukemia eukaryotic translation initiation factor 4E
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 101 interactors: ADH1B ANKRD2 ARID3A ARNT ATF2 ATXN1 AURKA AXIN1 BANP BCL2 BCL6 CASP8AP2 CCNT1 CDK1 CDK2 CDK6 CHFR CREBBP CSNK2A1 DAXX EGFR EIF4E ELF4 EP300 FOS GATA2 HDAC1 HDAC2 HDAC3 HHEX HIPK2 HTT KAT5 KAT6A MAPK11 MAPK14 MDM2 MED7 MXD1 MYB MYC NCOA2 NCOR1 NCOR2 NFKB1 NR3C1 NR4A1 PAWR PAXIP1 PCBD2 PIAS1 PIAS2 PIN1 PLAGL1 PLSCR1 POLR2E PPARG PSMA3 RARA RB1 RBX1 RELA RNF111 RNF125 RNF4 RPL11 RXRA SENP2 SH3GL1 SIAH2 SIN3A SIRT1 SKI SMAD3 SP1 SP100 SRF STAT3 SUMO1 SUMO2 SUMO3 SUV39H1 SYNE2 TDG TERF2IP TGFBR1 TGFBR2 TGIF1 THRA TOPBP1 TP53 TP63 TP73 TRIM24 TRIM27 TRIM69 UBE2I UBE2U UBE3A ZBTB16 ZFYVE9 25 interactors: APP CD83 EIF4B EIF4EBP1 EIF4EBP2 EIF4EBP3 EIF4ENIF1 EIF4G1 EIF4G2 EIF4G3 EMX2 GEMIN5 KANK2 MAPKAPK5 MKNK1 MKNK2 PML PRDM4 PRKCA PRKCB PRKCG RPS6KA5 TDO2 TRIM27 UBXN11
Entrez ID 5371 1977
HPRD ID 00023 00591
Ensembl ID ENSG00000140464
Uniprot IDs P29590 P06730 Q32Q75
PDB IDs 1BOR 1IPB 1IPC 1WKW 2GPQ 2V8W 2V8X 2V8Y 2W97 3AM7 3TF2 3U7X 4AZA 4DT6 4DUM
Enriched GO Terms of Interacting Partners?
Tagcloud ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
4g  amount  bp1  corticosterone  decreases  deficiency  diazoxide  diminished  dramatic  efficiency  eif4g  epitrochlearis  eukaryotic  fractional  gastrocnemius  glucagon  hormones  initiation  injection  lowered  modulating  muscle  postprandial  ribosomal  skeletal  soleus  synthesis  translation 
Tagcloud (Difference) ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
4g  amount  bp1  corticosterone  decreases  deficiency  diazoxide  diminished  dramatic  efficiency  eif4g  epitrochlearis  eukaryotic  fractional  gastrocnemius  glucagon  hormones  initiation  injection  lowered  modulating  muscle  postprandial  ribosomal  skeletal  soleus  synthesis  translation 
Tagcloud (Intersection) ?